Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Clinical trial NCT07321652 · RECRUITING
Trial details
- NCT number
- NCT07321652
- Sponsor
- Alliance for Clinical Trials in Oncology
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-30
- Primary completion
- 2028-09-30
- Enrollment
- 466
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.